U.S. Professional Services Stock News

NasdaqGS:SLDP
NasdaqGS:SLDPAuto Components

Solid Power (SLDP) Valuation Check As Electrolyte Commercialization And Partnerships Progress

Solid Power (SLDP) is in focus after reporting first quarter 2026 results alongside progress on its electrolyte commercialization plans, giving you fresh numbers and project updates to weigh against the current share price. See our latest analysis for Solid Power. Solid Power’s recent earnings update, electrolyte progress with SK On and Samsung SDI, and funding raise come after a volatile period, with a 1-day share price return of negative 12.71% and a 1-year total shareholder return of very...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope Unveils AgentSkope As Investors Weigh AI Automation Prospects

Netskope (NasdaqGS:NTSK) has introduced AgentSkope, an AI-driven agentic operations platform for automating security and network workflows. The new platform brings a suite of AI-powered agents designed to handle routine and complex operational tasks for security and network teams. This launch adds a fresh product to Netskope's portfolio in automated cybersecurity operations, an area where many enterprises are seeking more efficiency. Netskope trades at $11.4, with the stock showing a 14.5%...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences (CAI) Turns Q4 Profit After US$517 Million Quarterly Loss Testing Bullish Thesis

Caris Life Sciences (CAI) closed FY 2025 with Q4 revenue of US$292.9 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$812.0 million and a trailing basic EPS loss of US$3.22, set against a 97% year over year revenue increase and expectations for earnings to grow about 70.5% per year with profitability projected within three years. Over recent periods, the company has seen quarterly revenue move from US$101.6 million in Q3 2024 to US$129.9 million in Q4 2024, then to...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept’s ALS Survival Signal Reframes Cortisol Modulation And Growth Outlook

Corcept Therapeutics reported long term survival data from its DAZALS Phase 2 trial of dazucorilant in ALS. Patients receiving 300 mg daily experienced an 87% reduction in risk of death at two years. The trial did not meet its primary functional endpoint, but the survival benefit attracted attention at the ENCALS 2025 meeting. For investors tracking NasdaqCM:CORT, this new ALS data adds another layer to the story around Corcept Therapeutics beyond its core cortisol modulation work. The...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Is It Too Late To Consider Micron Technology (MU) After A 661% One Year Surge?

If you are wondering whether Micron Technology's share price still reflects fair value after a strong run, the key question is what the current market price is really paying for. The stock last closed at US$646.47, with returns of 25.0% over 7 days, 71.2% over 30 days, 105.0% year to date, and a very large 1 year gain of 661.0% that is roughly 7x. Recent headlines have focused on Micron Technology's position within the semiconductor industry and its role in supplying memory and storage for...
NYSE:RBA
NYSE:RBACommercial Services

Is It Too Late To Reassess RB Global (RBA) After Its Recent Share Price Surge?

Investors may be wondering if RB Global at around US$103 a share is still offering value or if most of the upside is already priced in. The stock has been fairly steady year to date, with a 0.1% return. However, that headline number masks a 5.8% gain over the past month, a small 0.8% slip in the last week, and a return of 97.8% over three years and 85.2% over five years. Recent coverage has focused on RB Global's role in the Commercial Services sector and how investors are reacting to its...
NasdaqGS:BL
NasdaqGS:BLSoftware

BlackLine Founder Exit Puts AI Growth And Q1 Execution In Focus

BlackLine (NasdaqGS:BL) reported strong Q1 results, highlighting momentum across its financial automation platform. Founder Therese Tucker has retired, marking a key leadership transition for the company. Management highlighted significantly expanded adoption of BlackLine's AI-powered financial software. BlackLine focuses on software that automates and streamlines finance and accounting workflows, an area where many enterprises are still early in their digital modernization. As more...
NasdaqGM:TTD
NasdaqGM:TTDMedia

Trade Desk (TTD) Margin Slippage Tests Bullish Narratives On AI And Connected TV

Trade Desk (TTD) closed out FY 2025 with Q4 revenue of US$846.8 million and basic EPS of US$0.39. Trailing twelve month revenue reached US$2.9 billion and EPS came in at US$0.91, underpinned by trailing earnings growth of 12.8% year over year. Over recent quarters, the company has seen revenue move from US$616.0 million and EPS of US$0.10 in Q1 2025 to US$846.8 million and EPS of US$0.39 in Q4 2025, with trailing net profit margin of 15.3% compared with 16.1% a year earlier, setting the tone...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Globalstar (GSAT) Quarterly Losses Deepen And Reinforce Bear Concerns On Earnings Volatility

Globalstar (GSAT) has wrapped up FY 2025 with fourth quarter revenue of US$72 million and a basic EPS loss of US$0.11, while trailing twelve month revenue came in at US$273 million alongside a full year basic EPS loss of US$0.15. Over recent periods the business has seen quarterly revenue range from US$60 million to US$74 million, with EPS swinging between a profit of US$0.13 and losses including US$0.16. This gives investors a mixed picture on how consistently revenue is translating into...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Is Grab Holdings (GRAB) Now A Potential Opportunity After Mixed Multi‑Year Share Performance?

This article explores whether Grab Holdings at around US$3.77 may represent a bargain or a value trap, and walks through key signals that can help you judge the stock for yourself. The share price performance has been mixed: a 1.3% decline over the last week, a 6.5% gain over the last month, returns of 25.8% decline year to date and 23.5% decline over the past year, set against a 17.4% gain over three years and a 65.9% decline over five years. Recent news around Grab Holdings has focused on...
NYSE:TXT
NYSE:TXTAerospace & Defense

Textron Expands Asia Pacific Footprint As Citation Ascend Enters Service

Textron Aviation, a unit of Textron (NYSE:TXT), has opened a significantly expanded service facility at Essendon Fields Airport in Melbourne to support customers across Asia-Pacific. The company has also begun initial deliveries of its new Cessna Citation Ascend business jets to NetJets, marking the first handovers of the model. For Textron, aviation services and business jets sit at the core of its aerospace focus, and the Asia-Pacific region is an important area for corporate and charter...
NasdaqGS:IBOC
NasdaqGS:IBOCBanks

International Bancshares (IBOC) High 49.8% Margin Tests Growth Focus In Bullish Valuation Narratives

International Bancshares (IBOC) has wrapped up FY 2025 with fourth quarter total revenue of US$212.2 million and basic EPS of US$1.72, supported by trailing 12 month revenue of US$827.1 million and EPS of US$6.63. Over recent periods, total revenue has ranged from US$194.9 million in Q1 2025 to US$216.3 million in Q3 2025, while quarterly basic EPS has moved between US$1.56 and US$1.85 as investors track how these earnings feed into the trailing net profit margin of 49.8%. With that margin...
NYSE:TOST
NYSE:TOSTDiversified Financial

Toast (TOST) Margin Jump To 5.6% Tests Bullish Long Term Profit Stories

Toast (TOST) has just wrapped up FY 2025 with revenue of about US$3.3b in the second half and basic EPS of US$0.35, while full year trailing twelve month figures sit at US$6.2b of revenue and EPS of US$0.59. This sets a clear snapshot of its recent earnings power. Over the past few reporting periods the company has seen revenue move from US$2.6b and EPS of US$0.16 in the second half of 2024 to US$2.9b and EPS of US$0.24 in the first half of 2025, and then to US$3.3b and EPS of US$0.35 in the...